Product details
Catalog number BNUM2054-50
Price for BNUM2054-50
Size / count 1x 50 µL
This antibody recognizes proteins of 80-200 kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This MAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA) from pleural mesotheliomas (rarely or weakly CEA) . Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix.Primary antibodies are available purified, or with a selection of fluorescent CF® Dyes and other labels. CF® Dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.
The catalog number for Carcinoembryonic Antigen (CEA) / CD66 (rC66/1009), 1mg/mL is BNUM2054-50.
Carcinoembryonic Antigen (CEA) / CD66 (rC66/1009), 1mg/mL is available in the following size(s): 1x 50 µL.
Carcinoembryonic Antigen (CEA) / CD66 (rC66/1009), 1mg/mL is currently made to order / not held in immediate stock. Contact us for lead time.
Carcinoembryonic Antigen (CEA) / CD66 (rC66/1009), 1mg/mL is manufactured by Biotium.
Estimated delivery time for Carcinoembryonic Antigen (CEA) / CD66 (rC66/1009), 1mg/mL is approximately 15 business day(s), depending on your location.
The safety data sheet for Carcinoembryonic Antigen (CEA) / CD66 (rC66/1009), 1mg/mL is available here: https://biotium.com/wp-content/uploads/2018/06/SDS-primary-antibodies.pdf.
This antibody recognizes proteins of 80-200 kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This MAb does not react with nonspecific cross-reacting a
The host species used in production is listed under product specifications on the datasheet, and is relevant when selecting a compatible secondary antibody for your assay.
Differences typically involve clone, conjugate, host species, or validated applications. Compare the respective datasheets, or contact us with both catalogue numbers for a direct comparison.
Yes, custom antibody development and private-label production services are available. Contact our sales team to discuss your target, timeline, and quantity requirements.